WebFeb 1, 2024 · The Management of Myelomeningocele Study (MOMS), a randomized trial of prenatal versus postnatal repair for myelomeningocele, found that prenatal surgery resulted in reduced hindbrain herniation and need for shunt diversion at 12 months of age and better motor function at 30 months. WebRepair of myelomeningocele; Resection of malformed pulmonary tissue, or placement of a thoraco-amniotic shunt as a treatment of either of the following: Congenital cystic adenomatoid malformation; or Extralobar pulmonary sequestration; Thoracoamniotic shunt for pleural effusions; Twin reversed arterial perfusion (TRAP);
The CuRe Trial: Cellular Therapy for In Utero Myelomeningocele Repair
WebPrenatal repair of spina bifida. Fetal surgery for myelomeningocele is a delicate surgical procedure where fetal surgeons open the uterus and close the opening in the baby's back while they are still in the womb. Fetal spina bifida surgery is shown to offer significantly better results than traditional repair after birth. WebThe trial’s results directly compared outcomes of prenatal surgery versus postnatal repair in 183 patients. The study showed that fetal surgery for spina bifida greatly reduces the need to divert fluid from the brain, improves mobility and improves the chances that a child will be able to walk independently. peripheral artery hospital
Myelomeningocele Repair Johns Hopkins Center for …
WebConclusions: This limited series of patients suggests that myelomeningocele can be repaired in utero with minimal morbidity to either the mother or her fetus. A larger study will be needed to substantiate this low morbidity and to determine the extent of any neurologic benefit of early surgery. Publication types Case Reports MeSH terms WebFeb 17, 2024 · open repair, but had lower rates of preterm births compared to laparatomy. Fetoscopic repair had higher rates of dehiscence and leakage from the repair site (P < .01). Authors conclude that fetoscopic repair is a promising alternative to surgery for myelomeningocele, pending improvement in dehiscence and leakage (Kabagambe, 2024). peripheral artery obstruction disease